The picture shows Japanese people walking into Ueno Zoo in Tokyo. Photo by Lu Shaowei, a reporter from China News Agency
In addition, if people suffer from health damage after vaccination, the Japanese government will pay the corresponding medical expenses according to the relief system stipulated in the vaccination law.
The Japanese government plans to ensure the use of vaccines by the first half of 2021, at a cost of about 670 billion yen (about US $6.37 billion). The Japanese government has basically reached a vaccine supply agreement with several relevant pharmaceutical companies in Europe and the United States.
As the current vaccine is still in the research and development stage, experts expect that the vaccine will not be available until the end of the year. Novel coronavirus pneumonia is the first priority for the new medical care workers and the elderly who are likely to turn to severe diseases.
The specific vaccination work is carried out by the local governments such as towns and villages, and the relevant expenses are planned to be borne by the central government and not required to be borne by the local government.
On the other hand, some people have also voiced their unwillingness to vaccinate. They think that the vaccine development time is short, the clinical verification may not be sufficient, and the safety cannot be effectively guaranteed. (end)